000 01148 a2200325 4500
005 20250515061113.0
264 0 _c20070424
008 200704s 0 0 eng d
022 _a0025-8105
024 7 _a10.2298/mpns0610427p
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPilipović, Nada
245 0 0 _aEffects of Alendronate on bone mass in women with osteoporosis.
_h[electronic resource]
260 _bMedicinski pregled
_c
300 _a427-35 p.
_bdigital
500 _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAlendronate
_xtherapeutic use
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aOsteoporosis, Postmenopausal
_xdrug therapy
700 1 _aBranković, Slobodan
700 1 _aVujasinović-Stupar, Nada
773 0 _tMedicinski pregled
_gvol. 59
_gno. 9-10
_gp. 427-35
856 4 0 _uhttps://doi.org/10.2298/mpns0610427p
_zAvailable from publisher's website
999 _c16902291
_d16902291